PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor

Background: Gliomas are aggressive tumors with various molecular and clinical characteristics and exhibit strongly resistance to radio-chemotherapy. Programmed cell death 1 ligand 2 (PD-L2) is a cell surface protein, which was reported in many cancers, modulating cancer-associated immune responses,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhi-liang, Li, Guan-zhang, Wang, Qiang-wei, Bao, Zhao-shi, Wang, Zheng, Zhang, Chuan-bao, Jiang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343813/
https://www.ncbi.nlm.nih.gov/pubmed/30713802
http://dx.doi.org/10.1080/2162402X.2018.1541535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343813/
https://www.ncbi.nlm.nih.gov/pubmed/30713802
http://dx.doi.org/10.1080/2162402X.2018.1541535

Ejemplares similares